COVID-19 and Obesity: What the Research Shows About Risk

Among the many risk factors researchers have studied since the pandemic began, obesity stands out as one of the most consistent. Hundreds of studies across different countries and populations have reached a similar conclusion: a higher body mass index (BMI) is linked to a meaningfully greater risk of severe illness from COVID-19.

How strong is the link?

Research has found that body mass index behaves as a strong, linear risk factor for severe COVID-19 outcomes, meaning the risk rises steadily as BMI increases rather than only appearing above a specific threshold. Recent studies have estimated the risk of COVID-19 hospitalisation increases by roughly 5 to 10% for every additional point of BMI. Obesity has been specifically linked to higher rates of hospitalisation, admission to critical care and the development of serious complications during a COVID-19 infection.

Who is most affected

Research has found the impact of higher BMI on COVID-19 outcomes was most pronounced in people in their 40s and 50s and in people of Black ethnicity, suggesting the risk isn't distributed evenly across all groups. This has prompted researchers to look more closely at how obesity intersects with other risk factors, including age, ethnicity and existing health conditions, rather than treating it as an isolated variable.

Why obesity increases COVID-19 risk

The exact biological mechanisms are still being studied, but several biologically plausible pathways have been proposed and are considered likely to contribute causally rather than being coincidental. These include the way excess body fat can impair lung function and reduce respiratory reserve, chronic low-grade inflammation associated with obesity that may worsen the body's immune response to infection and a higher prevalence of related conditions such as type 2 diabetes and cardiovascular disease, which are separately linked to worse COVID-19 outcomes.

Is this specific to COVID-19?

Obesity has long been recognised as a risk factor for complications from other respiratory infections too, including seasonal flu, so this pattern isn't entirely unique to COVID-19. What has stood out during the pandemic is how consistently the link has been demonstrated across such a large number of independent studies, which has strengthened confidence that the relationship is real rather than a statistical artefact of any single dataset.

Does this apply to children too?

Research specifically looking at children and adolescents has also identified obesity as a risk factor for more severe illness from COVID-19 in the paediatric population, though children overall remain at much lower risk of severe COVID-19 than adults regardless of weight. This means obesity is worth factoring into risk assessments for children with COVID-19, without it changing the broader picture that severe illness in children remains comparatively rare.

A modifiable risk factor

Unlike age or certain underlying health conditions, excess weight is considered a modifiable risk factor, meaning it's one that can potentially be changed. This is part of why health bodies have highlighted the COVID-19 research as an additional reason, alongside the many other established health benefits, to support weight management where appropriate. It isn't about placing blame on individuals; it's about recognising that meaningful, gradual changes in this specific risk factor are achievable in a way that age or genetics aren't.

What this means practically

If you have a higher BMI, this research doesn't mean severe illness is inevitable if you catch COVID-19, but it is a reasonable factor to discuss with your GP, particularly around vaccination priority, eligibility for antiviral treatment if you test positive and general advice on managing your risk. Staying up to date with eligible COVID-19 vaccinations remains one of the most effective ways to reduce risk regardless of BMI.

How this fits with wider NHS weight guidance

The COVID-19 research on obesity hasn't introduced a genuinely new public health message so much as it has reinforced and added further weight to an existing one that health professionals have been communicating for many years already. NHS guidance on healthy weight has long highlighted reduced risk of type 2 diabetes, cardiovascular disease and certain cancers as reasons to support weight management where it's appropriate for an individual and the COVID-19 evidence is best understood as one more data point within that established picture rather than a standalone reason on its own. Crash diets or drastic short-term changes aren't what the evidence supports; gradual, sustainable changes made with support from a GP or dietitian remain the recommended approach.

It's also worth being clear about what this research doesn't say. It doesn't mean every person with a higher BMI will experience severe COVID-19 and it doesn't mean people within a typical weight range are automatically protected from severe illness, since many other risk factors, including age and underlying health conditions, matter independently. BMI is one contributing factor among several, not a single determining one and it should be weighed alongside age, vaccination status and existing health conditions when thinking about personal risk overall.

A quick recap

A large and consistent body of research has identified higher BMI as a strong, linear risk factor for severe COVID-19, with the highest impact seen in people in their 40s and 50s. The mechanisms likely involve impaired lung function, chronic inflammation and related conditions like diabetes and unlike many other risk factors, weight is one that can potentially be modified gradually over time with appropriate professional support, patience, consistency and realistic expectations about pace.

Frequently asked questions

Does losing weight reduce COVID-19 risk if I catch it now?

Weight management takes time to affect underlying health, so it isn't a quick fix against an active infection, but it's a reasonable long-term step that may reduce your risk profile alongside vaccination and other health measures.

Is obesity considered when assessing eligibility for COVID-19 antiviral treatment?

Antiviral treatment eligibility in the UK is based on a specific list of high-risk conditions rather than BMI alone, though obesity often coexists with conditions that do qualify, such as type 2 diabetes. Your GP can assess your individual eligibility.

Does obesity increase the risk of long COVID?

Some research has suggested a link between obesity and a higher risk of persistent symptoms after COVID-19, though this area is less extensively studied than the acute severity research.

Is the obesity and COVID-19 link the same in every country studied?

The overall pattern of higher BMI increasing risk has been found consistently across many countries and populations, though the strength of the association has varied somewhat depending on the study population and local factors, including differences in healthcare access and the prevalence of other underlying health conditions.

Should children with a higher BMI be considered higher risk from COVID-19?

Research has identified obesity as a risk factor for more severe illness in children too, though severe COVID-19 remains uncommon in children overall regardless of weight.

Does the type of obesity, such as where fat is carried, make a difference?

Some research has suggested central or abdominal obesity may carry a somewhat different risk profile to overall BMI alone, though BMI remains the most widely used and studied measure in COVID-19 research to date. Talk to your GP if you want a fuller, more personalised picture of your risk, since they can consider your full health history alongside BMI rather than relying on a single number in isolation.